ACW 34.8% 6.2¢ actinogen medical limited

Ann: ACW December 2023 quarterly activity report & Appendix 4C, page-5

  1. 4,191 Posts.
    lightbulb Created with Sketch. 1200
    Cash is always an issue for any emerging company. I'm confident that with the next round of money from the government that we will get through to interim trial results of xanaCIDD. Those results, if successful, will push the sp up significantly and also awaken one or two big pharmas. If the results are mediocre then we wait for xanaMia results in 2025. I remain bullish.

    IMHO & DYOR
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
0.016(34.8%)
Mkt cap ! $166.3M
Open High Low Value Volume
4.5¢ 6.2¢ 4.4¢ $1.491M 28.50M

Buyers (Bids)

No. Vol. Price($)
1 50000 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.3¢ 100000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.